Table 1.
Before surgery | During surgery and PACU | Statistics | |
---|---|---|---|
Haemodynamics | |||
Systolic arterial pressure (mmHg) | 144 ± 22 | 112 ± 11 | P < 0.021 |
Diastolic arterial pressure (mmHg) | 84 ± 15 | 68 ± 7 | P = 0.053 |
Heart rate (bpm) | 92 ± 12 | 69 ± 7 | P < 0.003 |
Shedding products, plasma | |||
Syndecan-1 (ng/ml) | 21.0 ± 3.6 | 19.7 ± 5.1 | P = 0.312 |
Hyaluronic acid (ng/ml) | 38.0 ± 6.9 | 27.7 ± 5.3 | P < 0.016 |
Heparan sulfate (μg/ml) | 3.4 ± 0.9 | 5.5 ± 0.8 | P < 0.001 |
Shedding products, urine | |||
Syndecan-1 (ng/ml) | 42.9 (36.9–139.8) | 24.0 (15.6–46.0) | P < 0.028 |
Hyaluronic acid (ng/ml) | 10.8 (8.2–29.0) | 35.5 (30.9–37.1) | P < 0.043 |
Heparan sulfate (μg/ml) | 5.5 (5.1–5.9) | 5.7 (5.3–6.7) | P < 0.043 |
Data are the mean ± SD or median (25th–75th percentiles), as appropriate
PACU postoperative care unit